Home »
Academic Articles & Research Papers
Showing 6 of 6 academic articles
Sepideh Parvizpour, Jafar Razmara, Mohammad M. Pourseif, Yadollah Omidi • BioImpacts
(2019)
Introduction: Triple-negative breast cancer (TNBC) is an important subtype of breast cancer, which occurs in the absence of estrogen, progesterone and HER-2 receptors. According to the recent studies, TNBC may be a cancer testis antigen (CT...
DOAJ
Open Access (DOAJ)
DOI: 10.15171/bi.2019.06
Dipsikha Biswas, Logan Slade, Luke Duffley, Neil Mueller et al. • Cell Death Discovery
(2021)
Proposed mechanism. A Doxorubicin (DOX) targets the BCAA catabolic pathway in TNBCs, by downregulating BCKDK and augmenting clearance of intracellular BCKAs. B Genetic or pharmacological (high BT2 concentration) inhibition of BCKDK results ...
DOAJ
Open Access (DOAJ)
DOI: 10.1038/s41420-021-00602-0
Xuanzhao Chen, Zeyan Li, Meihua Liang, Ziyang Zhang et al. • World Journal of Surgical Oncology
(2023)
Abstract Background Triple-negative breast cancer (TNBC) is the most heterogenous and aggressive subtype of breast cancer. Chemotherapy remains the standard treatment option for patients with TNBC owing to the unavailability of acceptable t...
DOAJ
Open Access (DOAJ)
DOI: 10.1186/s12957-023-03078-7
Petra Ilenič, Ajda Herman, Erik Langerholc, Barbara Gazić et al. • Journal of Bone Oncology
(2024)
Background: As compared to endocrine responsive breast cancer bone is less frequent site of distant recurrence in triple-negative breast cancer (TNBC). A biomarker which predicts bone recurrence would allow a more personalized treatment app...
DOAJ
Open Access (DOAJ)
DOI: 10.1016/j.jbo.2023.100518
Stephen D. Williams, Tunde M. Smith, LaMonica V. Stewart, Amos M. Sakwe • Cells
(2022)
Physiological changes such as hypoxia in the tumor microenvironment (TME) endow cancer cells with malignant properties, leading to tumor recurrence and rapid progression. Here, we assessed the effect of hypoxia (1% Oxygen) on the tumor supp...
DOAJ
Open Access (DOAJ)
DOI: 10.3390/cells11193007
Oh JH, Jeong DS, Kim CY • Experimental & molecular medicine
(2026)
PMC
PMC Public Access (View-Only)
DOI: 10.1038/s12276-026-01861-6
PMC: PMC13737077